IDEAYA Biosciences, Inc.

IDYA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001676725

SEC filings (opens in a new tab)

In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding IDEAYA Biosciences, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of IDYA: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	209	2	206	−1
Shares	91.9M	17.2K	92.0M	+86.3K (+0.1%)
Value	$2.91B	$544.3K	$2.36B	−$547.1M (−18.8%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (34)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to IDYA in Q4 2024
Institution	Shares	Value	% of portfolio
Norges Bank	520,810	$13.4M	0.00%
MPM Oncology Impact Management LP	414,035	$10.6M	1.51%
WCM Investment Management, LLC	241,894	$6.03M	0.01%
Superstring Capital Management LP	227,102	$5.84M	5.13%
Neo Ivy Capital Management	130,806	$3.36M	0.68%
Trexquant Investment LP	107,147	$2.75M	0.03%
Fountainhead AM, LLC	64,556	$1.66M	0.30%
HighVista Strategies LLC	47,728	$1.23M	0.46%
Guggenheim Capital LLC	31,389	$806.7K	0.01%
B. Metzler seel. Sohn & Co. AG	27,276	$701.0K	0.01%
Police & Firemen's Retirement System of New Jersey	17,687	$454.6K	0.00%
Raymond James Financial Inc	16,769	$430.9K	0.00%
Tema ETFs LLC	16,066	$412.9K	0.17%
KLP Kapitalforvaltning AS	14,900	$382.9K	0.00%
EntryPoint Capital, LLC	14,670	$377.0K	0.16%
Aigen Investment Management, LP	10,899	$280.1K	0.05%
CIBC World Markets Corp	7,904	$203.1K	0.00%
MAI Capital Management	2,250	$57.8K	0.00%
GF Fund Management Co. Ltd.	1,815	$46.6K	0.00%
Caitong International Asset Management Co., Ltd	1,452	$37.3K	0.04%
R Squared Ltd	1,350	$34.7K	0.03%
BFSG, LLC	400	$10.3K	0.00%
Aster Capital Management (DIFC) Ltd	163	$4.19K	0.00%
Fourth Dimension Wealth, LLC	100	$2.57K	0.00%
Huntington National Bank	97	$2.49K	0.00%
Massmutual Trust Co FSB	66	$1.70K	0.00%
Gables Capital Management Inc.	50	$1.28K	0.00%
Aventura Private Wealth, LLC	46	$1.18K	0.00%
Northwestern Mutual Wealth Management Co	44	$1.13K	0.00%
Amundi	33	$820	0.00%
UMA Financial Services, Inc.	31	$797	0.00%
Larson Financial Group LLC	29	$745	0.00%
Riverview Trust Co	19	$488	0.00%
SBI Securities Co., Ltd.	12	$308	0.00%

Sold out (35)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of IDYA in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Boxer Capital, LLC	2,202,812	$69.8M
BVF Inc	1,409,993	$44.7M
Soleus Capital Management, L.P.	1,049,314	$33.2M
Macquarie Group Ltd	638,884	$20.2M
Holocene Advisors, LP	562,848	$17.8M
Ghisallo Capital Management LLC	175,000	$5.54M
StemPoint Capital LP	132,703	$4.20M
Artia Global Partners LP	62,992	$2.00M
Bank of Montreal	52,865	$1.63M
Connor, Clark & Lunn Investment Management Ltd.	50,370	$1.60M
Monashee Investment Management LLC	35,000	$1.11M
Nicholas Investment Partners, LP	29,625	$938.5K
Martingale Asset Management L P	21,678	$686.8K
HRT Financial LP	20,405	$646.0K
Readystate Asset Management LP	16,423	$520.3K
Bayesian Capital Management, LP	12,686	$401.9K
Allianz Asset Management GmbH	12,400	$392.8K
Graham Capital Management, L.P.	8,839	$280.0K
Entropy Technologies, LP	8,674	$274.8K
Principal Financial Group Inc	7,720	$244.6K
Balyasny Asset Management LLC	7,605	$240.9K
Bellevue Group AG	7,200	$228.1K
Callan Capital, LLC	6,726	$213.1K
Paloma Partners Management Co	6,708	$212.5K
Acadian Asset Management LLC	4,405	$139.0K
Quantbot Technologies LP	2,627	$83.2K
Values First Advisors, Inc.	2,345	$74.3K
Ci Investments Inc.	1,799	$57.0K
ADAR1 Capital Management, LLC	1,000	$31.7K
STRS Ohio	800	$25.3K
Wolff Wiese Magana LLC	140	$4.44K
Park Place Capital Corp	25	$792
Global Retirement Partners, LLC	12	$380
Fortitude Family Office, LLC	5	$158
Capital Performance Advisors LLP	1	$32

Not filed for Q4 2024 yet (2)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IDYA in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Chartwell Investment Partners, LLC	14,931	$473.0K
Halpern Financial, Inc.	2,250	$71.3K